Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ERAMUNE-01: ART Intensification + IL-7 in HIV
NCT01019551Phase 2Completed
- Sponsor
- Objectif Recherche Vaccins SIDA
- Start
- Sep 2010
- Primary completion
- Jul 2012
- Modality
- Cytokines & Interferons, Fc-Fusion Proteins
- Countries
- 4
01
Overview
A Phase 2 trial of efineptakin alfa in human immunodeficiency virus type 1 infection (HIV-1), sponsored by Objectif Recherche Vaccins SIDA. Started Sep 2010; status: completed.
02
Drugs
efineptakin alfa
03
Conditions
human immunodeficiency virus type 1 infection (HIV-1)
Beyond the preview
Go deeper on NCT01019551.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01019551.